Jakubowiak, A. J., Siegel, D. S., Martin, T., Wang, M., Vij, R., Lonial, S., . . . Jagannath, S. (2013). Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study. Nature Publishing Group.
Styl ChicagoJakubowiak, A J., et al. Treatment Outcomes in Patients With Relapsed and Refractory Multiple Myeloma and High-risk Cytogenetics Receiving Single-agent Carfilzomib in the PX-171-003-A1 Study. Nature Publishing Group, 2013.
Citace podle MLAJakubowiak, A J., et al. Treatment Outcomes in Patients With Relapsed and Refractory Multiple Myeloma and High-risk Cytogenetics Receiving Single-agent Carfilzomib in the PX-171-003-A1 Study. Nature Publishing Group, 2013.